Unlock instant, AI-driven research and patent intelligence for your innovation.

Inhibitors of cognitive decline

An alkyl, pharmaceutical technology for compounds derived from plant extracts capable of addressing chemical and biological instability

Inactive Publication Date: 2016-09-28
COGNITION THERAPEUTICS
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Further, chemical and biological instability may also be a serious problem for intravenous dosing

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhibitors of cognitive decline
  • Inhibitors of cognitive decline
  • Inhibitors of cognitive decline

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0249]The preparation of the compounds of the present invention may involve the protection and deprotection of various chemical groups. The need for protection and deprotection, and the selection of suitable protecting groups, can be readily determined by those skilled in the art. The chemistry of protecting groups can be found, for example, in T.W. Greene and P.G.M. Wuts, Protective Groups in Organic Synthesis, 3rd Edition, Wiley & Sons, Inc., New York (1999), which is incorporated herein by reference in its entirety .

[0250] Reactions can be monitored according to any suitable method known in the art. For example, product formation can be detected by spectroscopic means such as NMR spectroscopy (eg 1 H or 13 C), infrared spectroscopy, spectrophotometry (eg, UV-visible), mass spectroscopy, or monitoring by chromatographic methods such as high performance liquid chromatography (HPLC) or thin layer chromatography (TLC).

[0251] Compounds of embodiments of the present inv...

Embodiment 1

[0341] A. Extraction of conditioned ginger oil: reaction of ginger oil with 4-chlorobenzylamine, followed by reduction with sodium borohydride in methanol, and fractionation using column chromatography

[0342] Ginger oil (10 g) was dissolved in toluene (250 mL) and 4-chlorobenzylamine (3.4 g) was added. The mixture was kept under a nitrogen atmosphere and heated at reflux for 16 hours with removal of water through a Dean-Stark distillation apparatus. At this point, the Dean-Stark trap was removed, and the reaction mixture was cooled to 0°C on an ice bath. With vigorous stirring, a solution of sodium borohydride (10 g) in methanol (100 mL) was added portionwise over 30 minutes. When the addition was complete, the mixture was heated at reflux for 16 hours. At this point, the reaction mixture was cooled to room temperature and poured into saturated aqueous sodium bicarbonate (300 mL). The resulting mixture was concentrated by rotary evaporation, and the aqueous residue was pa...

Embodiment 2

[0363] A. Extraction of conditioned ginger oil: reaction of ginger oil with 4-trifluoromethylbenzylamine, followed by reduction with sodium borohydride in methanol, and fractionation using column chromatography

[0364] Ginger oil (10 g) was dissolved in toluene (250 mL) and 4-trifluoromethylbenzylamine (3.5 g) was added. The mixture was kept under a nitrogen atmosphere and heated at reflux for 16 hours with removal of water through a Dean-Stark distillation apparatus. At this point, the Dean-Stark trap was removed, and the reaction mixture was cooled to 0°C on an ice bath. With vigorous stirring, a solution of sodium borohydride (10 g) in methanol (100 mL) was added portionwise over 30 minutes. When the addition was complete, the mixture was heated at reflux for 16 hours. At this point, the reaction mixture was cooled to room temperature and poured into saturated aqueous sodium bicarbonate (300 mL). The resulting mixture was concentrated by rotary evaporation, and the aque...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and / or abatement of cognitive decline and / or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds / compositions of the invention.

Description

[0001] This application is the PCT international application PCT / US2010 / 030130 submitted on April 6, 2010, which entered the Chinese national phase on December 9, 2011. The Chinese patent application number is 201080025771.6, and the invention name is "Inhibitor of Cognitive Decline" A divisional application of an invention patent application. technical field [0002] The present invention relates to the production and identification of compounds, compositions and methods derived from plant extracts useful in the treatment and alleviation of cognitive decline and Alzheimer's disease. Background technique [0003] Cognitive decline, such as memory loss, confusion, impaired judgment, personality changes, disorientation, and loss of language skills, occurs in many people to varying degrees as they age. The most common, severe and irreversible form of cognitive decline is Alzheimer's disease, which is currently often fatal. [0004] Symptoms of cognitive decline and Alzheimer's...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C217/62C07C213/02C07C213/10A61K31/137A61P25/28
CPCC07C213/02C07C213/10C07C217/62C07D207/08C07D211/22A61P25/28A61P43/00C07C211/27
Inventor G·M·里什顿S·卡塔拉诺
Owner COGNITION THERAPEUTICS